These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1102235)

  • 21. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
    Gaynor MF; Wright GC; Vondracek S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of food on blood hydralazine levels and response in hypertension.
    Shepherd AM; Irvine NA; Ludden TM
    Clin Pharmacol Ther; 1984 Jul; 36(1):14-8. PubMed ID: 6734044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in rats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1684-90. PubMed ID: 3064752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
    Abraham PA; Halstenson CE; Matzke GR; Keane WF
    J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of hydralazine HCl administration in horses.
    Bertone JJ
    Am J Vet Res; 1988 May; 49(5):618-21. PubMed ID: 3395006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar-Kyoto and spontaneously hypertensive rats.
    Tsoucaris D; Benetos A; Legrand M; London GM; Safar ME
    J Hypertens; 1995 Feb; 13(2):243-9. PubMed ID: 7615955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.
    Kuzniar J; Skret A; Piela A; Szmigiel Z; Zaczek T
    Obstet Gynecol; 1985 Oct; 66(4):453-8. PubMed ID: 4047535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single versus multiple daily administration of hydralazine in the maintenance treatment of hypertension. Clinical and pharmacokinetic aspects.
    Henningsen NC; Hanson A; Wernersson B
    Acta Med Scand; 1982 May; 211(3):179-85. PubMed ID: 7044051
    [No Abstract]   [Full Text] [Related]  

  • 31. Baroreflex sensitivity as a determinant of responses to hydralazine in dogs.
    Vidrio H
    J Pharmacol Exp Ther; 1983 Jan; 224(1):247-51. PubMed ID: 6848745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
    Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
    Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients.
    Velasco M; Romero E; Bertoncini H; Urbina-Quintana A; Guevara J; Hernández-Pieretti O
    Br J Clin Pharmacol; 1978 Sep; 6(3):217-20. PubMed ID: 687499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioassay of the vasodepressor and cardiostimulatory effects of hydralazine and pyridazine derivative (DL-150) in hypertensive patients.
    Pasotti C; Nicrosini F; Marchetti M; Manzini A; Nicolis FB
    Farmaco Prat; 1976 Sep; 31(9):453-62. PubMed ID: 1010019
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
    Knorr A; Garthoff B
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral dose size on hydralazine kinetics and vasodepressor response.
    Shepherd AM; Irvine NA; Ludden TM; Lin MS; McNay JL
    Clin Pharmacol Ther; 1984 Nov; 36(5):595-600. PubMed ID: 6488679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension.
    McGoon MD; Seward JB; Vlietstra RE; Choo MH; Moyer TP; Reeder GS
    Br Heart J; 1983 Dec; 50(6):579-85. PubMed ID: 6652000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydralazine in the management of symptomatic sinus bradycardia.
    Weiss AT; Rod JL; Gotsman MS; Lewis BS
    Eur J Cardiol; 1981; 12(5):261-70. PubMed ID: 7250168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.